Peripheral Arterial Disease Trial, Recruiting NCT06253312 Sponsor: Clinical Centre of Serbia Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06253312
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older with a history of a condition where fatty deposits have narrowed or blocked the arteries in your legs or feet (called peripheral arterial disease).
  • You must have received treatment for this condition between 1st January 2015 and 1st January 2022.
  • Any type of surgical or procedural treatment is included, whether it was done through small tubes inserted into blood vessels, a combination of methods, or traditional open surgery.

Who may not be able to join:

  • You may not be eligible if you are currently pregnant.
  • You may not be eligible if you are under 18 years of age.
  • You may not be eligible if your condition caused a sudden, severe loss of blood flow to your limb (confirm with trial site).
  • You may not be eligible if your artery disease was caused by something other than fatty deposit build-up, such as a cycling-related condition, an injury, or a tear in the artery wall.
  • You may not be eligible if your condition was managed without any surgical or procedural treatment (for example, through medication or lifestyle changes only).
  • You may not be eligible if you had a major amputation as the first treatment for your condition.
  • You may not be eligible if your life expectancy is estimated to be less than 2 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joao Rocha Neves, MD PhD, Univeristy of Porto

Phone: +381644961020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Clinical Centre of Serbia
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
1 May 2025

Where this trial is recruiting

🇷🇸 Serbia

Primary endpoints

All-cause mortality; Major adverse limb event (MALE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov